US Stock MarketDetailed Quotes

MAIA MAIA Biotechnology

Watchlist
  • 2.890
  • +0.040+1.40%
Close Sep 20 16:00 ET
  • 2.890
  • 0.0000.00%
Post 16:04 ET
69.09MMarket Cap-1783P/E (TTM)

MAIA Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
26.60%11.58M
9.03%8.27M
-34.70%7.15M
-34.70%7.15M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
3.56%10.95M
--14.06M
-Cash and cash equivalents
26.60%11.58M
9.03%8.27M
-34.70%7.15M
-34.70%7.15M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
3.56%10.95M
--14.06M
Receivables
-54.07%177.69K
-55.23%155.97K
-52.22%144.68K
-52.22%144.68K
-55.18%114.43K
90.41%386.83K
--348.38K
593.42%302.79K
593.42%302.79K
--255.31K
-Other receivables
-54.07%177.69K
-55.23%155.97K
-52.22%144.68K
-52.22%144.68K
-55.18%114.43K
90.41%386.83K
--348.38K
593.42%302.79K
593.42%302.79K
--255.31K
Other current assets
6.74%259.73K
-31.66%272.58K
-51.53%268.68K
-51.53%268.68K
-10.15%414.12K
-5.12%243.33K
70.00%398.87K
916.41%554.32K
916.41%554.32K
--460.92K
Total current assets
22.92%12.02M
4.40%8.7M
-35.94%7.56M
-35.94%7.56M
-55.12%6.63M
13.55%9.78M
-20.84%8.33M
10.64%11.81M
10.64%11.81M
--14.78M
Non current assets
Non current deferred assets
----
-98.21%13.24K
--0
--0
--365.14K
-57.32%489.65K
-19.26%737.69K
-67.59%211.2K
-67.59%211.2K
--0
Other non current assets
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
-10.31%2.8K
-10.31%2.8K
--2.8K
Total non current assets
-99.43%2.8K
-97.83%16.04K
-98.69%2.8K
-98.69%2.8K
13,040.71%367.94K
-57.18%492.45K
-19.20%740.49K
-67.31%214K
-67.31%214K
--2.8K
Total assets
17.05%12.02M
-3.95%8.72M
-37.06%7.57M
-37.06%7.57M
-52.64%7M
5.22%10.27M
-20.71%9.07M
6.13%12.02M
6.13%12.02M
--14.78M
Liabilities
Current liabilities
Payables
-18.42%1.26M
66.09%1.87M
40.59%1.64M
40.59%1.64M
20.31%1.23M
48.73%1.55M
25.95%1.13M
21.36%1.17M
21.36%1.17M
--1.02M
-accounts payable
-18.42%1.26M
66.09%1.87M
40.59%1.64M
40.59%1.64M
20.31%1.23M
48.73%1.55M
25.95%1.13M
21.36%1.17M
21.36%1.17M
--1.02M
Current accrued expenses
21.15%1.39M
15.97%1.43M
67.24%1.69M
67.24%1.69M
237.83%2.1M
-1.14%1.15M
43.00%1.23M
46.30%1.01M
46.30%1.01M
--622.96K
Current deferred liabilities
----
----
----
----
----
----
----
----
----
--32.59K
Current liabilities
7.28%3.51M
30.30%4.91M
51.03%4.94M
51.03%4.94M
68.95%4.15M
5.66%3.27M
54.94%3.77M
52.33%3.27M
52.33%3.27M
--2.46M
Non current liabilities
Derivative product liabilities
4,296.91%5.35M
4,166.15%9.57M
777.22%2.15M
777.22%2.15M
--103.41K
--121.6K
--224.4K
--245.34K
--245.34K
----
Total non current liabilities
4,296.91%5.35M
4,166.15%9.57M
777.22%2.15M
777.22%2.15M
--103.41K
--121.6K
--224.4K
--245.34K
--245.34K
--0
Total liabilities
160.95%8.86M
262.85%14.48M
101.73%7.09M
101.73%7.09M
73.16%4.25M
9.58%3.39M
64.17%3.99M
63.76%3.51M
63.76%3.51M
--2.46M
Shareholders'equity
Share capital
73.92%2.37K
87.18%2.06K
55.02%1.7K
55.02%1.7K
25.75%1.38K
62.11%1.37K
38.54%1.1K
44.59%1.1K
44.59%1.1K
--1.1K
-common stock
73.92%2.37K
87.18%2.06K
55.02%1.7K
55.02%1.7K
25.75%1.38K
62.11%1.37K
38.54%1.1K
44.59%1.1K
44.59%1.1K
--1.1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-53.13%-80.93M
-49.09%-72.05M
-44.73%-63.98M
-44.73%-63.98M
-47.67%-57.72M
-50.32%-52.85M
-51.72%-48.32M
-55.45%-44.21M
-55.45%-44.21M
---39.09M
Paid-in capital
40.78%84.11M
24.10%66.31M
22.27%64.47M
22.27%64.47M
17.58%60.51M
42.86%59.75M
30.76%53.43M
40.17%52.73M
40.17%52.73M
--51.47M
Gains losses not affecting retained earnings
14.40%-22.18K
-18.88%-30.05K
-1.80%-16.26K
-1.80%-16.26K
15.26%-43.77K
-525.04%-25.91K
-1,568.56%-25.27K
---15.97K
---15.97K
---51.65K
Total stockholders'equity
-54.00%3.16M
-213.41%-5.76M
-94.39%477.51K
-94.39%477.51K
-77.71%2.75M
3.19%6.87M
-43.61%5.08M
-7.33%8.51M
-7.33%8.51M
--12.33M
Total equity
-54.00%3.16M
-213.41%-5.76M
-94.39%477.51K
-94.39%477.51K
-77.71%2.75M
3.19%6.87M
-43.61%5.08M
-7.33%8.51M
-7.33%8.51M
--12.33M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 26.60%11.58M9.03%8.27M-34.70%7.15M-34.70%7.15M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M3.56%10.95M--14.06M
-Cash and cash equivalents 26.60%11.58M9.03%8.27M-34.70%7.15M-34.70%7.15M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M3.56%10.95M--14.06M
Receivables -54.07%177.69K-55.23%155.97K-52.22%144.68K-52.22%144.68K-55.18%114.43K90.41%386.83K--348.38K593.42%302.79K593.42%302.79K--255.31K
-Other receivables -54.07%177.69K-55.23%155.97K-52.22%144.68K-52.22%144.68K-55.18%114.43K90.41%386.83K--348.38K593.42%302.79K593.42%302.79K--255.31K
Other current assets 6.74%259.73K-31.66%272.58K-51.53%268.68K-51.53%268.68K-10.15%414.12K-5.12%243.33K70.00%398.87K916.41%554.32K916.41%554.32K--460.92K
Total current assets 22.92%12.02M4.40%8.7M-35.94%7.56M-35.94%7.56M-55.12%6.63M13.55%9.78M-20.84%8.33M10.64%11.81M10.64%11.81M--14.78M
Non current assets
Non current deferred assets -----98.21%13.24K--0--0--365.14K-57.32%489.65K-19.26%737.69K-67.59%211.2K-67.59%211.2K--0
Other non current assets 0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K-10.31%2.8K-10.31%2.8K--2.8K
Total non current assets -99.43%2.8K-97.83%16.04K-98.69%2.8K-98.69%2.8K13,040.71%367.94K-57.18%492.45K-19.20%740.49K-67.31%214K-67.31%214K--2.8K
Total assets 17.05%12.02M-3.95%8.72M-37.06%7.57M-37.06%7.57M-52.64%7M5.22%10.27M-20.71%9.07M6.13%12.02M6.13%12.02M--14.78M
Liabilities
Current liabilities
Payables -18.42%1.26M66.09%1.87M40.59%1.64M40.59%1.64M20.31%1.23M48.73%1.55M25.95%1.13M21.36%1.17M21.36%1.17M--1.02M
-accounts payable -18.42%1.26M66.09%1.87M40.59%1.64M40.59%1.64M20.31%1.23M48.73%1.55M25.95%1.13M21.36%1.17M21.36%1.17M--1.02M
Current accrued expenses 21.15%1.39M15.97%1.43M67.24%1.69M67.24%1.69M237.83%2.1M-1.14%1.15M43.00%1.23M46.30%1.01M46.30%1.01M--622.96K
Current deferred liabilities --------------------------------------32.59K
Current liabilities 7.28%3.51M30.30%4.91M51.03%4.94M51.03%4.94M68.95%4.15M5.66%3.27M54.94%3.77M52.33%3.27M52.33%3.27M--2.46M
Non current liabilities
Derivative product liabilities 4,296.91%5.35M4,166.15%9.57M777.22%2.15M777.22%2.15M--103.41K--121.6K--224.4K--245.34K--245.34K----
Total non current liabilities 4,296.91%5.35M4,166.15%9.57M777.22%2.15M777.22%2.15M--103.41K--121.6K--224.4K--245.34K--245.34K--0
Total liabilities 160.95%8.86M262.85%14.48M101.73%7.09M101.73%7.09M73.16%4.25M9.58%3.39M64.17%3.99M63.76%3.51M63.76%3.51M--2.46M
Shareholders'equity
Share capital 73.92%2.37K87.18%2.06K55.02%1.7K55.02%1.7K25.75%1.38K62.11%1.37K38.54%1.1K44.59%1.1K44.59%1.1K--1.1K
-common stock 73.92%2.37K87.18%2.06K55.02%1.7K55.02%1.7K25.75%1.38K62.11%1.37K38.54%1.1K44.59%1.1K44.59%1.1K--1.1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -53.13%-80.93M-49.09%-72.05M-44.73%-63.98M-44.73%-63.98M-47.67%-57.72M-50.32%-52.85M-51.72%-48.32M-55.45%-44.21M-55.45%-44.21M---39.09M
Paid-in capital 40.78%84.11M24.10%66.31M22.27%64.47M22.27%64.47M17.58%60.51M42.86%59.75M30.76%53.43M40.17%52.73M40.17%52.73M--51.47M
Gains losses not affecting retained earnings 14.40%-22.18K-18.88%-30.05K-1.80%-16.26K-1.80%-16.26K15.26%-43.77K-525.04%-25.91K-1,568.56%-25.27K---15.97K---15.97K---51.65K
Total stockholders'equity -54.00%3.16M-213.41%-5.76M-94.39%477.51K-94.39%477.51K-77.71%2.75M3.19%6.87M-43.61%5.08M-7.33%8.51M-7.33%8.51M--12.33M
Total equity -54.00%3.16M-213.41%-5.76M-94.39%477.51K-94.39%477.51K-77.71%2.75M3.19%6.87M-43.61%5.08M-7.33%8.51M-7.33%8.51M--12.33M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data